City

Bethesda (1)

Columbus (1)

Madison (1)

New York (1)

Pittsburgh (1)

Sacramento (1)

Seattle (1)

Overall Status

Recruiting (1)

Terminated (1)

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Fred Hutchinson Cancer Center (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

aldesleukin (1)

autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes (1)

cisplatin (1)

cyclophosphamide (1)

elimusertib (1)

gemcitabine hydrochloride (1)

laboratory biomarker analysis (1)

therapeutic conventional surgery (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

procedure (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

advanced pleural malignant mesothelioma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,

Recruiting

Advanced Bile Duct Carcinoma
+33 more

Cisplatin
+2 more

Sacramento, California
+6 more

Aug 11, 2022

Advanced Pleural Malignant Mesothelioma, HLA-A*0201 Positive Cells Present, Recurrent Non-Small Cell Lung Carcinoma Trial in

Terminated

Has Results

Advanced Pleural Malignant Mesothelioma
+10 more

Aldesleukin
+4 more

Seattle, Washington

Fred Hutch/University of Washington Cancer Consortium

Aug 16, 2021